Benadryl combined with Erbitux

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Vomiting Life Threatening 11/30/2005 42 Female 108 lb 1/11/2006 Physician United States
Primary
Concomitant
Hypersensitivity Life Threatening 12/13/2005 61 Male 185 lb 1/26/2006 Consumer United States
Primary
Concomitant
Pyrexia Other Serious 1/16/2006 82 Male 238 lb 1/27/2006 Consumer United States
Primary
Concomitant
Hypersensitivity Hospitalization 1/30/2006 69 Male 148 lb 2/3/2006 Other Health Professional United States
Primary
Concomitant
Skin Chapped Hospitalization 9/1/2005 63 Male 243 lb 2/8/2006 Consumer United States
Primary
Concomitant
Grand Mal Convulsion Other Serious 2/9/2006 Physician United States
Primary
Concomitant
Mucosal Inflammation Other Serious 1/31/2006 65 Male 150 lb 2/9/2006 Consumer United States
Primary
Concomitant
Vomiting Other Serious 1/10/2006 73 Female 2/9/2006 Consumer United States
Primary
Concomitant
Cardio-respiratory Arrest Other Serious 1/1/2006 60 Male 2/10/2006 Consumer United States
Primary
Concomitant
Pneumonia Hospitalization 2/1/2006 68 Male 170 lb 2/14/2006 Consumer United States
Primary
Concomitant
Loss Of Consciousness Other Serious 1/1/2006 76 Female 137 lb 2/22/2006 Consumer United States
Primary
Concomitant
Hypersensitivity Hospitalization 1/30/2006 69 Male 148 lb 2/24/2006 Other Health Professional United States
Primary
Concomitant
Anaphylactic Reaction Life Threatening 12/9/2004 60 Male 181 lb 3/3/2006 Other Health Professional United States
Primary
Concomitant
Blood Magnesium Decreased Other Serious 51 Male 141 lb 3/3/2006 Consumer United States
Primary
Concomitant
Skin Toxicity 9/7/2005 80 Female 3/3/2006 Consumer United States
Primary
Concomitant
Vomiting Other Serious 9/26/2005 60 Male 223 lb 3/3/2006 Consumer United States
Primary
Concomitant
Asthenia 9/22/2005 51 Male 3/3/2006 Physician United States
Primary
Concomitant
Infusion Related Reaction Hospitalization 10/11/2005 59 Female 3/3/2006 Other Health Professional United States
Primary
Concomitant
Anaphylactic Reaction Life Threatening 10/4/2005 63 Male 3/3/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 10/19/2005 70 Male 205 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash Generalised 10/1/2005 Male 157 lb 3/3/2006 Other Health Professional United States
Primary
Concomitant
Oedema Peripheral 10/1/2005 70 Male 3/3/2006 Physician United States
Primary
Concomitant
Swollen Tongue 10/26/2005 Male 126 lb 3/3/2006 Consumer United States
Primary
Concomitant
Blood Magnesium Decreased Other Serious 1/1/2005 70 Male 3/3/2006 Consumer United States
Primary
Concomitant
Blood Potassium Decreased 51 Female 3/3/2006 Consumer United States
Primary
Concomitant
Blood Magnesium Decreased 1/1/2005 70 Male 3/3/2006 Consumer United States
Primary
Concomitant
Blood Magnesium Decreased 1/1/2005 70 Male 3/3/2006 Consumer United States
Primary
Concomitant
Paraesthesia 10/1/2005 Male 3/3/2006 Other Health Professional United States
Primary
Concomitant
Medication Error 11/14/2005 64 Male 205 lb 3/3/2006 Pharmacist United States
Primary
Concomitant
Pruritus Other Serious 11/1/2005 55 Male 194 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash Papular 11/1/2005 65 Male 196 lb 3/3/2006 Other Health Professional United States
Primary
Concomitant
Ocular Hyperaemia 10/1/2005 68 Male 176 lb 3/3/2006 Other Health Professional United States
Primary
Concomitant
Urticaria Other Serious 11/20/2005 72 Female 152 lb 3/3/2006 Physician United States
Primary
Concomitant
White Blood Cell Count Decreased 1/1/2005 63 Male 3/3/2006 Consumer United States
Primary
Concomitant
Rash Generalised Other Serious 1/1/2005 70 Male 185 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash Generalised 12/1/2005 40 Male 214 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash Other Serious 56 Female 181 lb 3/3/2006 Consumer United States
Primary
Concomitant
Dermatitis Acneiform Other Serious 1/1/2005 50 Female 141 lb 3/3/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 12/19/2005 59 Male 183 lb 3/3/2006 Consumer United States
Primary
Concomitant
No Adverse Effect 1/10/2006 72 Male 3/3/2006 Consumer United States
Primary
Concomitant
Rash 1/1/2006 35 Male 187 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash Generalised 1/1/2006 54 Male 234 lb 3/3/2006 Consumer United States
Primary
Concomitant
Skin Discolouration 54 Male 183 lb 3/3/2006 Consumer United States
Primary
Secondary
Concomitant
Rash 1/1/2006 Male 161 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash 53 Female 3/3/2006 Other Health Professional United States
Primary
Concomitant
Hypomagnesaemia Other Serious 12/1/2005 65 Female 168 lb 3/3/2006 Consumer United States
Primary
Concomitant
Medication Error 1/12/2006 60 Male 163 lb 3/3/2006 Other Health Professional United States
Primary
Concomitant
Pruritus 1/19/2006 71 Female 3/3/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 1/20/2006 Male 3/3/2006 Physician United States
Primary
Concomitant
Pruritus 1/23/2006 59 Female 3/3/2006 Consumer United States
Primary
Concomitant
No Adverse Effect 1/25/2006 3/3/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 1/26/2006 Male 3/3/2006 Consumer United States
Primary
Concomitant
Blood Magnesium Decreased Other Serious 1/27/2006 54 Male 126 lb 3/3/2006 Consumer United States
Primary
Concomitant
Rash Hospitalization 3/3/2006 44 Male 157 lb 3/6/2006 Other Health Professional United States
Primary
Concomitant
Salivary Hypersecretion Life Threatening 11/16/2005 57 Male 240 lb 3/9/2006 Other Health Professional United States
Primary
Concomitant
Pyrexia Other Serious 1/1/2006 75 Female 121 lb 3/10/2006 Consumer United States
Primary
Concomitant
Pneumonia Hospitalization 2/1/2006 68 Male 170 lb 3/13/2006 Consumer United States
Primary
Concomitant
Syncope Other Serious 1/1/2006 76 Female 137 lb 3/13/2006 Consumer United States
Primary
Concomitant
Stridor Other Serious 56 Male 3/13/2006 Consumer United States
Primary
Concomitant
Pulmonary Embolism Other Serious 3/1/2006 49 Male 218 lb 3/16/2006 Consumer United States
Primary
Concomitant
Pruritus Other Serious 3/8/2006 60 Male 3/16/2006 Consumer United States
Primary
Concomitant
Vomiting Other Serious 8/1/2005 50 Male 3/17/2006 Consumer United States
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 12/19/2005 71 Male 143 lb 3/21/2006 Consumer United States
Primary
Concomitant
Erythema Other Serious 3/16/2006 Male 3/24/2006 Other Health Professional United States
Primary
Concomitant
Infusion Related Reaction Other Serious 3/16/2006 50 Male 3/24/2006 Consumer United States
Primary
Concomitant
Myocardial Infarction Other Serious 2/15/2006 63 Male 3/27/2006 Other Health Professional United States
Primary
Concomitant
Eye Infection Other Serious Female 3/30/2006 Consumer United States
Primary
Concomitant
Eye Infection Other Serious 3/30/2006 Consumer United States
Primary
Concomitant
Salivary Hypersecretion Life Threatening 11/16/2005 57 Male 240 lb 4/4/2006 Other Health Professional United States
Primary
Concomitant
Stridor Other Serious 11/4/2005 51 Male 4/4/2006 Consumer United States
Primary
Concomitant
Skin Discolouration Other Serious 2/3/2006 36 Female 4/5/2006 Other Health Professional United States
Primary
Concomitant
Grand Mal Convulsion Other Serious 78 Female 4/5/2006 Physician United States
Primary
Concomitant
Pyrexia Other Serious 3/2/2006 75 Female 121 lb 4/5/2006 Consumer United States
Primary
Concomitant
Flushing Hospitalization 3/30/2006 Male 4/6/2006 Physician United States
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 12/19/2005 71 Male 143 lb 4/12/2006 Consumer United States
Primary
Concomitant
Neoplasm Malignant Other Serious 2/15/2006 63 Male 4/12/2006 Other Health Professional United States
Primary
Concomitant
Refusal Of Treatment By Patient Other Serious 2/3/2006 55 Male 4/12/2006 Consumer United States
Primary
Concomitant
Skin Discolouration Other Serious 3/30/2006 Female 4/13/2006 Consumer United States
Primary
Concomitant
Dyspnoea Hospitalization 3/14/2006 64 Male 128 lb 4/12/2006 Other Health Professional United States
Primary
Concomitant
Respiratory Distress Other Serious 11/21/2005 69 Male 4/24/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Dyspnoea Life Threatening 4/17/2006 64 Male 278 lb 4/25/2006 Consumer United States
Primary
Concomitant
Rash Hospitalization 2/28/2006 54 Female 102 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Supraventricular Tachycardia Other Serious 5/4/2005 68 Female 99 lb 4/27/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Pruritus Other Serious 3/8/2006 55 Male 5/1/2006 Consumer United States
Primary
Concomitant
Bone Pain Other Serious 12/12/2005 53 Male 5/1/2006 Other Health Professional United States
Primary
Concomitant
Stomatitis Other Serious 4/27/2006 46 Male 256 lb 5/2/2006 Consumer United States
Primary
Concomitant
Pruritus Hospitalization 3/23/2006 62 Male 5/4/2006 Pharmacist United States
Primary
Concomitant
Hyperhidrosis Other Serious 4/1/2006 Male 5/10/2006 Physician United States
Primary
Concomitant
Respiratory Failure Hospitalization 9/19/2005 64 Male 5/10/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Dyspnoea Life Threatening 4/17/2006 64 Male 278 lb 5/15/2006 Consumer United States
Primary
Concomitant
Coma Other Serious 75 Male 5/16/2006 Consumer United States
Primary
Concomitant
Urticaria Other Serious 5/9/2006 64 Male 207 lb 5/16/2006 Consumer United States
Primary
Concomitant
Vomiting Other Serious 5/10/2006 41 Male 117 lb 5/16/2006 Consumer United States
Primary
Concomitant
Paraesthesia Other Serious 4/18/2006 Female 5/18/2006 Consumer United States
Primary
Concomitant
Blood Magnesium Decreased Other Serious 6/6/2005 51 Male 141 lb 5/30/2006 Consumer United States
Primary
Concomitant
White Blood Cell Count Decreased 1/1/2005 63 Male 5/30/2006 Consumer United States
Primary
Concomitant
Skin Chapped 12/1/2005 70 Male 185 lb 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Hospitalization 12/30/2005 58 Female 183 lb 5/30/2006 Other Health Professional United States
Primary
Concomitant
No Adverse Effect 1/9/2006 80 Female 5/30/2006 Consumer United States
Primary
Concomitant
Rash 5/1/2005 53 Female 5/30/2006 Other Health Professional United States
Primary
Concomitant
Infusion Related Reaction Other Serious 11/11/2005 78 Female 179 lb 5/30/2006 Other Health Professional United States
Primary
Concomitant
Infusion Related Reaction Life Threatening 1/20/2006 44 Male 5/30/2006 Physician United States
Primary
Concomitant
Infusion Related Reaction Other Serious 10/21/2005 61 Male 214 lb 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 1/18/2006 75 Female 126 lb 5/30/2006 Consumer United States
Primary
Concomitant
Blood Magnesium Decreased Other Serious 1/10/2005 55 Male 183 lb 5/30/2006 Consumer United States
Primary
Concomitant
Muscle Tightness 50 Female 108 lb 5/30/2006 Consumer United States
Primary
Concomitant
Nail Infection 12/1/2005 55 Female 201 lb 5/30/2006 Consumer United States
Primary
Concomitant
Dermatitis Acneiform 1/28/2006 36 Female 236 lb 5/30/2006 Consumer United States
Primary
Concomitant
Dermatitis Acneiform 12/1/2005 31 Male 181 lb 5/30/2006 Consumer United States
Primary
Concomitant
Pruritus Hospitalization 1/20/2006 78 Female 5/30/2006 Consumer United States
Primary
Concomitant
Paraesthesia 2/9/2006 60 Male 5/30/2006 Consumer United States
Primary
Concomitant
Injection Site Reaction 2/21/2006 81 Male 141 lb 5/30/2006 Consumer United States
Primary
Concomitant
Dermatitis Acneiform 1/1/2005 56 Male 260 lb 5/30/2006 Consumer United States
Primary
Concomitant
Nail Disorder Female 5/30/2006 Consumer United States
Primary
Concomitant
Anaphylactic Reaction Other Serious 2/23/2006 57 Male 5/30/2006 Consumer United States
Primary
Concomitant
Acne Other Serious 2/16/2006 41 Male 192 lb 5/30/2006 Consumer United States
Primary
Concomitant
Skin Lesion Other Serious 78 Female 152 lb 5/30/2006 Consumer United States
Primary
Concomitant
Rash Pustular Other Serious 2/27/2006 58 Male 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 3/2/2006 70 Male 5/30/2006 Physician United States
Primary
Concomitant
Infusion Related Reaction Hospitalization 3/3/2006 55 Male 5/30/2006 Consumer United States
Primary
Concomitant
Rash 3/3/2006 68 Male 181 lb 5/30/2006 Consumer United States
Primary
Concomitant
Rash Female 170 lb 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Other Serious 3/8/2006 50 Female 5/30/2006 Physician United States
Primary
Concomitant
Chills 3/20/2006 78 Male 161 lb 5/30/2006 Consumer United States
Primary
Concomitant
Dry Skin 3/1/2006 57 Male 216 lb 5/30/2006 Consumer United States
Primary
Concomitant
Malignant Neoplasm Progression Death 44 Male 5/30/2006 Other Health Professional United States
Primary
Concomitant
Rash Other Serious 1/1/2005 76 Female 148 lb 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction Life Threatening 3/23/2006 63 Male 152 lb 5/30/2006 Consumer United States
Primary
Secondary
Concomitant
Chills Other Serious 3/14/2006 49 Male 223 lb 5/30/2006 Consumer United States
Primary
Concomitant
Skin Reaction Other Serious 2/1/2006 46 Male 128 lb 5/30/2006 Consumer United States
Primary
Secondary
Concomitant
Colorectal Cancer Metastatic Hospitalization 30 Female 5/30/2006 Consumer United States
Primary
Concomitant
No Adverse Effect 4/5/2006 58 Male 168 lb 5/30/2006 Consumer United States
Primary
Concomitant
Hypomagnesaemia Other Serious 3/30/2006 75 Male 126 lb 5/30/2006 Consumer United States
Primary
Concomitant
Rash 4/2/2006 59 Male 218 lb 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction 4/4/2006 Male 5/30/2006 Physician United States
Primary
Concomitant
Skin Chapped Other Serious 1/1/2006 68 Male 168 lb 5/30/2006 Consumer United States
Primary
Concomitant
Infusion Related Reaction 4/12/2006 61 Male 128 lb 5/30/2006 Consumer United States
Primary
Concomitant
Rash 4/8/2006 74 Male 181 lb 5/30/2006 Consumer United States
Primary
Concomitant
Pyrexia 4/18/2006 Male 5/30/2006 Other Health Professional United States
Primary
Concomitant
Infusion Related Reaction Death 1/1/2006 69 Male 269 lb 5/30/2006 Consumer United States
Primary
Concomitant
Rash Other Serious 4/27/2006 Male 5/30/2006 Consumer United States
Primary
Concomitant
Feeling Hot 4/24/2006 Male 5/30/2006 Consumer United States
Primary
Concomitant
Pruritus Other Serious 5/5/2006 59 Female 6/1/2006 Consumer United States
Primary
Concomitant
Dyspnoea Life Threatening 4/17/2006 64 Male 278 lb 6/1/2006 Consumer United States
Primary
Concomitant
Vomiting Hospitalization 12/26/2005 75 Female 6/1/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Stent Occlusion Hospitalization 8/1/2005 71 Female 174 lb 6/5/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Stent Placement Life Threatening 4/28/2006 68 Female 161 lb 6/6/2006 Consumer United States
Primary
Concomitant
Sepsis Hospitalization 22 Female 6/7/2006 Consumer United States
Primary
Concomitant
Rash Other Serious 5/31/2006 50 Male 172 lb 5/31/2006 Other Health Professional United States
Primary
Concomitant
Respiratory Arrest Life Threatening 3/14/2006 65 Male 6/16/2006 Other Health Professional United States
Primary
Concomitant

Drug Data